Effect of propofol on sleep quality of critically ill patients

ISRCTN ISRCTN72847182
DOI https://doi.org/10.1186/ISRCTN72847182
Secondary identifying numbers N/A
Submission date
15/10/2009
Registration date
29/10/2009
Last edited
29/10/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Eumorfia Kondili
Scientific

Intensive Care Unit
University Hospital of Heraklion
Crete
71110
Greece

Phone +30 2810 392 585
Email konde@med.uoc.gr

Study information

Study designRandomised placebo-controlled cross-over trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffect of propofol on sleep quality of critically ill patients: a randomised placebo controlled cross-over trial
Study acronymPropofol vs Placebo
Study objectivesTo assess the effect of propofol on sleep quality of mechanically ventilated critically ill patients.
Ethics approval(s)Ethics Committee of University Hospital of Heraklion, Crete approved on the ... (ref: 11868)
Health condition(s) or problem(s) studiedCritically ill patients
InterventionEach patient will be studied on two consecutive nights (from 9:00 pm to 7:00 am). In each patient two nights polysomnography studies will be performed with or without propofol in random order. Propofol will be administered via continuous infusion. The rate (mc/Kgr/min) of sedation will be such as to achieve a score of 3 on the Ramsay Scale (response to commands) with no changes in the infusion rate during the study time. Single doses of sedatives or changes in the rate of infusion of sedatives will be not permitted during the study or for 4 hours before the study. Patients in whom the requirements for sedation as judged by the primary physician increased during the night will be excluded for further study and the study will be terminated at that point. The Ramsay Scale will be re-evaluated at the beginning (9:00pm) at the middle (2:00pm) and end (7:00am) of the study.

Patients will be followed up until their discharge from the hospital.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Propofol
Primary outcome measure1. Effect of propofol on sleep quality, measured immediately after each study night
2. Sleep architecture, scored manually by an expert physician not involved in the study.
3. Central apnoeas, arousals and awakenings, defined using standard criteria
4. Total sleep fragmentation, calculated as the sum of arousals and awakenings per hour of sleep
Secondary outcome measuresNot provided at time of registration
Overall study start date20/10/2009
Completion date05/10/2010

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants10
Key inclusion criteria1. Critically ill patients, on mechanical ventilation for at least 48 hours, haemodynamically stable
2.Ventilated on assist mode
3. No respiratory distress
4. Aged between 18 and 85 years, inclusive, either sex
Key exclusion criteria1. Aged less than 18 and greater than 85 years
2. Severe haemodynamic instability
3. Pregnancy
4. End stage disease
5. Respiratory distress
6. Acute brain injury
Date of first enrolment20/10/2009
Date of final enrolment05/10/2010

Locations

Countries of recruitment

  • Greece

Study participating centre

Intensive Care Unit
Crete
71110
Greece

Sponsor information

Cretan Critical Care Society (Greece)
Research organisation

Intensive Care Unit
University Hospital of Heraklion
Crete
71110
Greece

Phone +30 2810 392 636
Email georgop@med.uoc.gr
Website http://www.icuheraklion.gr

Funders

Funder type

Research organisation

Cretan Critical Care Society (Greece)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan